glp-1 comparison GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 Drug Comparison in Diabetes
Description
There are two separate formularies, one for HMO and one for PPO
A reduction in the expression levels of the AGE receptor facilitated this effect
No decisions, no stress, no excuses
The most common side effects are gastrointestinal: nausea (30-44%), diarrhea (19-30%), constipation (10-24%), and occasional vomiting (9-24%)
The most important marker is hemoglobin A1c (HbA1c) , which reflects average blood glucose levels over the preceding two to three months
Compounded versions are not FDA-approved and haven't undergone the same clinical testing as brand-name GLP-1 medications
